The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,110.00
Ask: 12,114.00
Change: -46.00 (-0.38%)
Spread: 4.00 (0.033%)
Open: 12,092.00
High: 12,138.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Work-from-home guidance and face masks can be back in winter in UK

Mon, 13th Sep 2021 11:19

(Alliance News) - Guidance to work from home and the mandatory use of face masks are likely to be retained as options in the Covid winter plan due to be set out by UK Prime Minister Boris Johnson.

The prime minister will tell the nation on Tuesday how the country can learn to live with the virus, underlining how vaccinations will be a central part of the response to coronavirus in the coming months.

Covid laws that are no longer required will be ditched and plans for vaccine passports for nightclubs and other large crowd venues have been shelved.

The travel traffic lights system is also expected to be scrapped and PCR tests will no longer be required for fully vaccinated travellers.

Speaking on Monday, Work & Pensions Secretary Therese Coffey said some regulations may still be needed as the NHS prepares to battle both Covid and seasonal flu in the winter months.

Asked about maintaining the work-from-home advice, she told BBC Breakfast of the need to keep some rules on the table, adding: "Whether that's with what you just mentioned or making sure statutory sick pay can be paid from day one rather than day four, as tends to happen in more regular times.

"These are the sensible measures I think that we're going to keep."

On the issue of masks, she added: "The prime minister will be setting out the Covid winter plan tomorrow. I think my approach, and I see that with a lot of employers' organisations, is about having a situation-specific approach."

It comes after Health Secretary Sajid Javid said on Sunday that vaccine passports were a "huge intrusion into people's lives" and there were no current plans to go ahead with them.

He said: "You have got to be really, really certain that's what you want to do. We have looked at it and whilst we will keep it in reserve I am pleased to say that we will not be going ahead."

However, Coffey said the introduction of vaccine passports had not been "ruled out forever".

She said: "As Sajid Javid set out yesterday, although the formal decision is still to be made, but having reflected and looked at the details of the proposal that it's not deemed necessary at this moment in time.

"But they haven't been ruled out forever. It's reflecting the fact that a lot of young people have come forward and got their vaccinations over the summer."

The government has yet to set out the plans for booster vaccinations, which are expected to be given to the most vulnerable people first.

A decision has also not yet been made by the UK's chief medical officers on extending the Covid vaccination programme to healthy 12 to 15-year-olds.

The Joint Committee on Vaccination & Immunisation has already said the margin of benefit is considered too small to support universal vaccination of healthy youngsters at this time.

Elsewhere, Neil Ferguson, whose modelling was instrumental to the UK going into lockdown in March 2020, has said he is in favour of a booster programme.

The scientist, from Imperial College London, and a member of the Scientific Advisory Group for Emergencies, told BBC Radio 4's Today programme on Monday that in the absence of social distancing measures, which he did agree with, "we are reliant on immunity building up in the population".

He added: "That happens two ways – one through vaccination, and one through people getting infected and so the faster we can roll our additional vaccination, the better in terms of stopping people getting severely ill but also in reducing transmission."

He said the UK had been leading in Europe on vaccination until recently but other countries such as Spain, Portugal, France, Italy and Ireland "have got higher vaccination levels than us and that's largely because they have rolled out vaccination of 12 to 15-year-olds faster than us.

"They also vaccinated more recently, and we know now that vaccine effectiveness decays over time, we always expected that, and so they have more immunity in the population.

"They also principally used the Pfizer vaccine which against Delta is somewhat more effective than the AstraZeneca vaccine, so there are a set of countries in Europe with considerably more population immunity than us and I think if we want to stop the risk of the large autumn and winter wave we need to boost immunity in the population."

Ferguson said vaccinating teenagers with a first shot was the priority as the UK looks at dealing with any autumn and winter surges in Covid. But he said evidence from Israel suggested booster shots for a wider population were "very effective at further driving down transmission and infection".

Asked whether a further lockdown could be ruled out, he said "I hope so" but added that "you can't rule out anything completely".

The issue of vaccine passports has caused growing disquiet among Tory ranks, as well as facing opposition from opposition parties and industry figures.

The decision not to implement them means measures in England deviate from those in Scotland, where a motion on their introduction was passed in the Scottish Parliament on Thursday, while a decision is expected in Wales next week.

Stormont ministers have yet to reach an official position on using vaccine access passports within Northern Ireland.

By Jane Kirby and Sam Blewett

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
Today 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.